JAGUAR HEALTH, INC. (JAGX) SEC News April 07, 2026, 12:35 UTC (19% Negative) JAGUAR HEALTH, INC. (JAGX) Reports Q2 2026 Financial Results Full text
Register to leave comments News bot April 7, 2026, 12:36 p.m. 📋 JAGUAR HEALTH, INC. (JAGX) - Financial Results Filing Date: 2026-04-07 Accepted: 2026-04-07 08:35:22 Event Type: Financial Results Event Details: JAGUAR HEALTH, INC. (JAGX) Reports the reporting period Financial Results JAGUAR HEALTH, INC. (JAGX) announced its financial results for the period ending the reporting period. Key Financial Highlights: Revenue: 11511 Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: Not disclosed 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2025 2024 Change ($) Change (%) Financial Highlights Loss From Operations 45.91K 30.83K $15.08K +48.90% Financial Highlights Net Loss Per Share 24.27 130.69 $-106.42 -81.43% 💼 Business Developments: PartnershipAcquisition: Not availableLicensingRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: JAGUAR HEALTH, INC.Ticker Symbol: JAGX
📋 JAGUAR HEALTH, INC. (JAGX) - Financial Results
Filing Date: 2026-04-07
Accepted: 2026-04-07 08:35:22
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: